NEW YORK, April 27, 2015 /PRNewswire/ -- Bronstein, Gewirtz
& Grossman, LLC is investigating potential claims on behalf of
purchasers of the securities of Celladon Corporation ("Celladon" or
the "Company") (NasdaqGM: CLDN -News). Such investors are
advised to contact Peretz Bronstein
or his investor relations coordinator Eitan
Kimelman at info@bgandg.com or 212-697-6484.
The investigation concerns whether Celladon and certain of its
officers and/or directors have violated Sections 10(b) and 20(a) of
the Securities Exchange Act of 1934.
On April 26, 2015, the Company
announced that "its Phase 2b CUPID2 trial did not meet its primary
and secondary endpoints. CUPID2 is a randomized, double-blind,
placebo-controlled, multinational trial evaluating a single,
one-time, intracoronary infusion of the cardiovascular gene therapy
agent MYDICAR(R) (AAV1/SERCA2a) versus placebo added to a maximal,
optimized heart failure drug and device regimen."
Following this news, shares of Celladon fell $10.78 or 78.80%, during intraday trading to
trade at at $2.90 on April 27, 2015.
If you are aware of any facts relating to this investigation, or
purchased shares of Celladon, you can assist this investigation by
contacting Peretz Bronstein or his
Investor Relations Coordinator Eitan
Kimelman of Bronstein, Gewirtz & Grossman, LLC at
212-697-6484 or via email info@bgandg.com. Those who inquire
by e-mail are encouraged to include their mailing address, email
and telephone number.
Bronstein, Gewirtz & Grossman, LLC is a corporate litigation
boutique. Our primary expertise is the aggressive pursuit of
litigation claims on behalf of our clients. In addition to
representing institutions and other investor plaintiffs in class
action security litigation, the firm's expertise includes general
corporate and commercial litigation, as well as securities
arbitration. Attorney advertising. Prior results do not guarantee
similar outcomes.
Contact:
Bronstein, Gewirtz & Grossman, LLC
Peretz Bronstein or Eitan Kimelman 212-697-6484
info@bgandg.com
To view the original version on PR Newswire,
visit:http://www.prnewswire.com/news-releases/shareholder-alert-bronstein-gewirtz--grossman-llc-announces-investigation-of-celladon-corporation-300072452.html
SOURCE Bronstein, Gewirtz & Grossman, LLC